Catalent Acquires Minority Interest In R.p. Scherer




Catalent Acquires Current Minority Interest in R.P. Scherer, Eberbach, Germany

Somerset, NJ, January 30, 2012 – Catalent Pharma Solutions, a leading global drug delivery technology company, today announced the signing of an agreement to acquire the remaining 49% minority share ownership of its R.P. Scherer GmbH & Co. KG subsidiary from Gelita AG. 

The completion of the transaction is subject to customary closing conditions including approval from regulatory authorities. Other terms of the transaction were not disclosed.

About Catalent

From drug and biologic development services to delivery technologies to supply solutions, Catalent Pharma Solutions has the deepest expertise, the broadest offerings and the most unique technologies in the industry. With over 75 years of experience, Catalent helps customers get more molecules to market faster, enhance product performance, and provide superior, reliable manufacturing and packaging solutions. Catalent employs more than 8,000 people at 20+ facilities worldwide and in fiscal year 2011 generated more than $1.6 billion in annual revenue. Catalent is headquartered in Somerset, NJ. 

more products. better treatments. reliably supplied.™